Mohammad Javad Tarrahi, Amir Hadi, Elham Karimi, Farnaz Shahdadian, Mohammad-Aref Tarrahi
Journal: International journal of clinical practice 2022;2022():9622546
PMID: 36105788
BACKGROUND
The present systematic review and meta-analysis of randomized controlled trials (RCTs) aimed at determining the effect of saffron supplementation on renal function.
METHODS
Electronic databases were searched up to February 2021. The risk of bias in individual studies was assessed using the Cochrane Collaboration tool. The overall weighted mean difference (WMD) and their 95% confidence intervals (CIs) were calculated using random-effect models. < 0.05 was considered statistically significant.
RESULTS
A total of 11 trials were included in this study. Saffron had beneficial effect on BUN (WMD = -0.69 mg/dl; 95% CI, -1.36 to -0.01; =0.046) compared to placebo, with significant heterogeneity ( = 49.6%, =0.037). However, it had no significant effect on serum Cr (WMD = 0.04 mg/dl; 95% CI: -0.01 to 0.09; =0.127).
CONCLUSION
It seems that saffron supplementation had no significant effect on Cr as a renal function factor. However, BUN reduction was significant in the saffron group compared to placebo.
Copyright © 2022 Elham Karimi et al.
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.